Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation, April 16, 2025, Meeting on the Med, Rome
Expert strategies discussed by experts. Join us for a panel not to be missed!
Panel title: Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation
@Alliance for Regenerative Medicine’s 2025 Cell and Gene Meeting on the Med
April 16, 4:30pm-5:15pm
Salone dei Cavalieri, Section 3&4
with
@John W. Hadden II, CEO, ViroCell Biologics (Moderator)
@Sadik Kassim, PhD, Chief Scientific Officer and Chief Technology Officer, Genomic Medicines Danaher Corporation
@Maryam Mokhtarzadeh, MD, Senior Director, Regulatory Strategy, @REGENXBIO
@Hilary Schultz, CEO and Founder, @Persephoni BioPartners
Come to our panel or find us here:
https://partneringone.informaconnect.com/event/800/company/112
#CGMed25 #cellandgenetherapy #CellandGeneTherapy #CellTherapy #GeneTherapy #advancedtherapies @Farzin Farzaneh, PhD @Nicholas Ostrout, Ph.D. @Traci Kyes